94 related articles for article (PubMed ID: 988340)
1. [Clinical significance of urinary fibrin-fibrinogen degradation products in renal disease].
Umitsu Y
Nihon Jinzo Gakkai Shi; 1976 Jun; 18(6):371-87. PubMed ID: 988340
[No Abstract] [Full Text] [Related]
2. Specific identification of urinary fibrinogen, fibrinogen degradation products, and cross-linked fibrin degradation products in renal diseases and after renal allotransplantation.
Scott WL; Francis CW; Knutson DW; Marder VJ
J Lab Clin Med; 1986 Jun; 107(6):534-43. PubMed ID: 3519810
[TBL] [Abstract][Full Text] [Related]
3. [Clinical significance of urinary fibrin/fibrinogen degradation products in renal disease. First report: Urinary fibrin/fibrinogen degradation products in primary glomerulonephritis (author's transl)].
Miyamura S
Nihon Jinzo Gakkai Shi; 1978 Jan; 20(1):67-78. PubMed ID: 650992
[No Abstract] [Full Text] [Related]
4. [Clinical significance of urinary fibrin/fibrinogen degradation products in renal disease. Second report: Urinary fibrin/fibrinogen degradation products in nephrotic syndrome. (author' transl)].
Miyamura S
Nihon Jinzo Gakkai Shi; 1978 Apr; 20(4):315-26. PubMed ID: 671855
[No Abstract] [Full Text] [Related]
5. [Fibrin degradation products in the urine in renal diseases].
Iversen BM; Ofstad J; Thunold S; Willassen Y
Tidsskr Nor Laegeforen; 1976 Jan; 96(2):91-3. PubMed ID: 766292
[No Abstract] [Full Text] [Related]
6. [Determination of fibrin and fibrinogen split products by their anticoagulant activity].
Belitser VA; Varetskaia TV; Tsynkalovskaia SN; Tsariuk LA; Shevchenko LI
Ukr Biokhim Zh; 1976; 48(4):521-32. PubMed ID: 982623
[TBL] [Abstract][Full Text] [Related]
7. Fibrinogen-fibrin degradation products in renal disorders.
Dube B; Srivastava PK; Padmanabhan R; Dube RK
Indian J Pathol Microbiol; 1979 Oct; 22(4):313-22. PubMed ID: 548482
[No Abstract] [Full Text] [Related]
8. [Significance of urinary fibrin/fibrinogen degradation products (FDP) measured by highly sensitive ELISA method in various renal diseases].
Shibata T; Sumie A; Ishii T; Tomo T; Magari Y; Sato J; Yasumori R; Nasu M
Nihon Jinzo Gakkai Shi; 1993 Jun; 35(6):687-94. PubMed ID: 8377281
[TBL] [Abstract][Full Text] [Related]
9. Significance of urinary fibrin/fibrinogen degradation products (FDP) D-dimer measured by a highly sensitive ELISA method with a new monoclonal antibody (D-D E72) in various renal diseases.
Shibata T; Magari Y; Kamberi P; Ishii T; Tomo T; Yasumori R; Nasu M
Clin Nephrol; 1995 Aug; 44(2):91-5. PubMed ID: 8529315
[TBL] [Abstract][Full Text] [Related]
10. [Urinary cross-linked FDP in various renal diseases].
Inuma H
Nihon Jinzo Gakkai Shi; 1994 Feb; 36(2):146-57. PubMed ID: 8139147
[TBL] [Abstract][Full Text] [Related]
11. Significance of the quantitative determination of "fibrin degradation products" in renal diseases.
Chin Med J (Engl); 1980 Jul; 93(7):483-6. PubMed ID: 6772396
[No Abstract] [Full Text] [Related]
12. [Diagnostic difficulties in renal diseases presenting no urinary changes or with minimal abnormalities].
Chodorowski Z; Muszkowska-Penson J; Stolarczyk J
Pol Tyg Lek; 1976 Aug; 31(31):1325-7. PubMed ID: 967741
[No Abstract] [Full Text] [Related]
13. [The fibrinolytic therapy in renal disease (author's transl)].
Kaburagi T; Yokoyama S; Tanaka K; Haniu T; Suzuki T; Mithunami K; Takayama S; Oguma S; Hatori T; Kishimoto T; Tomimoto K
Nihon Jinzo Gakkai Shi; 1980 Jan; 22(1):59-79. PubMed ID: 6991744
[No Abstract] [Full Text] [Related]
14. [Determination of fibrin (fibrinogen) degradation products in urine].
Andreenko GV; Podorol'skaia LV
Lab Delo; 1983; (4):35-8. PubMed ID: 6191081
[No Abstract] [Full Text] [Related]
15. [Origin of urinary FDP in children with renal diseases].
Yoshioka K; Iseki T; Ikeda H; Akano N; Uraoka Y; Miyata H; Maki S
Nihon Jinzo Gakkai Shi; 1982 Mar; 24(3):285-93. PubMed ID: 7120693
[No Abstract] [Full Text] [Related]
16. [Studies on fibrinolytic therapy in children with various renal diseases with special reference to changes of urinary FDP x D-dimer fragments].
Kamitsuji H; Iida Y; Omura R; Taira K; Tsukada S; Kusumoto K; Okamoto Y
Nihon Jinzo Gakkai Shi; 1982 Nov; 24(11):1251-9. PubMed ID: 7166891
[No Abstract] [Full Text] [Related]
17. [Clinical significance of urinary FDP-E measured by latex photometric immunoassay (LPIA) in the renal disease].
Kaizu K; Ito Y; Uriu K; Komine N; Hashimoto O; Eto S
Nihon Jinzo Gakkai Shi; 1991 Apr; 33(4):365-71. PubMed ID: 1875556
[TBL] [Abstract][Full Text] [Related]
18. [Urinary crosslinked fibrin degradation products in various renal diseases].
Kamitsuji H; Whitworth JA; Kincaid-Smith P
Nihon Jinzo Gakkai Shi; 1986 Aug; 28(8):1137-43. PubMed ID: 3807046
[No Abstract] [Full Text] [Related]
19. [Urinary FDP].
Hashimoto S; Sawa H
Rinsho Byori; 1983 May; 31(5):480-8. PubMed ID: 6632306
[No Abstract] [Full Text] [Related]
20. Clinical significance of urinary fibrin/fibrinogen degradation products (FDP) as measured by latex photometric immunoassay in renal diseases.
Kaizu K; Ito Y; Uriu K; Eto S
Nihon Jinzo Gakkai Shi; 1993 Jan; 35(1):29-34. PubMed ID: 8336397
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
